Company: CPMV
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001683168-25-002584
Chunk: 139

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1A
Chunk 139
---
 could be subject
to significant fluctuations. For instance, during the year ended December 31, 2024, the low and high trading prices of our common stock
ranged from $0.10 to $1.13 per share. Market prices for securities of early-stage pharmaceutical, biopharmaceutical, and other life sciences
companies have historically been particularly volatile.

 22 

Some of the factors that may cause the market price
of our common stock to fluctuate include:

    ·
    our limited cash position and our immediate need for additional capital;

    ·
    potential results from preclinical testing and clinical trial results, and our ability to obtain regulatory approvals for product candidates, and delays or failures to obtain such approvals;

    ·
    issues in manufacturing these product candidates;

    ·
    the entry into, or termination of, key agreements;

    ·
    the initiation of, material developments in, or conclusion of litigation to enforce or defend intellectual property rights or defend against the intellectual property rights of others;

    ·
    announcements by competitors of new commercial products, clinical progress or the lack thereof, significant contracts, or commercial relationships;

    ·
    the introduction of technological innovations or new therapies that compete with our potential products;

    ·
    the loss of key employees;

    ·
    general and industry-specific economic conditions that may affect our research and development expenditures;

    ·
    changes in the structure of healthcare payment systems;

    ·
    issuance of new shares of common stock from raising additional capital, which may not be available on acceptable terms, or at all; and

    ·
    period-to-period fluctuations in our financial results.

Moreover, the stock markets in general have experienced
substantial volatility that has often been unrelated to the operating performance of individual companies. These broad market fluctuations
may also adversely affect the trading price of our common stock.

In the past, following periods of volatility in the
market price of a company’s securities, stockholders have often instituted class action securities litigation against those companies.
Such litigation, if instituted, could result in substantial costs and diversion of management attention and resources, which could significantly
harm our financial position.

Our share price could decline as a result of short
sales.

When an investor sells stock that he does not own,
it is known as a short sale. The seller, anticipating that the price of the stock will go down, intends to buy stock to cover his/her
sale at a later date. If the price of the stock goes